All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Staff Writer
WASHINGTON – Next-generation sequencing-based tests are taking center stage on Friday, with the FDA seeking the public's feedback on two draft guidance documents intended to support President Barack Obama's Precision Medicine Initiative.